Outlook in 2014

Liver cancer is difficult to treat, and lethal if not caught early. But its most common causes, such as hepatitis viruses and obesity, can be prevented.

Changing crop selection and improving food storage might reduce global rates of liver cancer, says Felicia Wu.

Navigating the path that connects fatty liver disease to cancer has proved tricky.

A vaccine to prevent hepatitis B, the most common cause of liver cancer, has promise — and limitations.

Imbalances in gut bacteria have been implicated in the progression from liver disease to cancer. This insight opens the way to preventive treatments.

Antiviral medication is leading surgeons to re-evaluate how they treat hepatitis-induced liver cancer, writes Myron Schwartz.

Liver cancer strikes many more men than women — finding out why could lead to new ways of preventing the disease.

Drug companies have been fighting a losing battle against advanced liver cancer — but refinements of proven techniques along with radical new approaches could turn the tide.

People with the inherited bleeding disorder haemophilia lack factors that cause the blood to clot. The disease affects thousands of people around the world and has even played a part in historic events. By Neil Savage.

History explains why people with haemophilia, and their physicians, are cautious to believe that a cure is in sight, says Stephen Pemberton.

Pills made from lettuce leaves could help to prevent one of the most serious complications of haemophilia treatment.

The hunt is on for ways to diagnose and treat the joint problems that are now the main chronic problem in haemophilia.

Repairing the faulty genes that cause haemophilia could ultimately cure the disease, but it will be a tough challenge.

A promising therapy curtails clotting inhibitors rather than replacing proteins that promote blood clotting.

In the study of haemophilia, man really does have a best friend.

Extending the life of clotting factors may improve quality of life for people with haemophilia.

Melanoma is an aggressive cancer that normally starts in the skin. It can strike anyone but is most common in people with pale skin, and it is getting more common. By David Holmes.